Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

NCT06133374 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06133374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06133374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2024
Completion date
May 30, 2028
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillary thyroid cancer